ERIS
Eris Lifesciences Limited
Pharmaceuticals
Share price
₹1,328
Market cap
₹18,369 Cr
1Y return
▼ 24%
A pharmaceutical manufacturer and marketer, ERIS Lifesciences produces branded and generic drugs across multiple therapeutic areas including cardiovascular, gastroenterology, and anti-infective segments. The company operates manufacturing facilities and distributes medications through established distribution networks to serve both domestic and international markets. It focuses on developing and delivering cost-effective pharmaceutical formulations for diverse patient populations.
Investors holding Eris Lifesciences Limited
1.03%
Latest move
HSBC Mutual FundNew position
HSBC Mutual Fund entered Eris Lifesciences Limited with 14,25,613 shares, a 1.03% stake worth ₹207.57 crore at ₹1455.40 apiece.
Sign in to read more
Whales made 3 more moves in Eris Lifesciences Limited
Sign in to see who is buying and selling.
Sign in to find out